Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Blinded, IDEAL Stage 3, Multi-Centre, Randomised Controlled Trial to Assess NeuroSAFE Robotic Assisted Radical Prostatectomy (RARP) vs Standard Robotic Assisted Radical Prostatectomy (RARP) in Men With Prostate Cancer

NCT03317990 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03317990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03317990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Blinded, IDEAL Stage 3, Multi-Centre, Randomised Controlled Trial to Assess NeuroSAFE Robotic Assisted Radical Prostatectomy (RARP) vs Standard Robotic Assisted Radical Prostatectomy (RARP) in Men With Prostate Cancer
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 9, 2018
Completion date
December 31, 2027
Enrollment
407 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer